Additionally, a miR-199a-5p-targeted inhibitor could significantly enhance PIAS3 and p27 expression and ultimately suppress the tumour growth in a xenograft model of OS, which represents a potential therapeutic approach that may be valuable for OS therapy. The gene discussed is PIAS3; the disease is neoplasm.